Business Description
Mithra Pharmaceuticals SA
ISIN : BE0974283153
Compare
Compare
Traded in other countries / regions
MITRA.BelgiumMITPF.USA1TM.Germany0R91.UK IPO Date
2019-10-02Description
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -44.8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 31.84 | |||||
| EV-to-Forward-EBIT | 2.38 | |||||
| EV-to-Forward-EBITDA | 2.21 | |||||
| EV-to-Forward-Revenue | 1.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MITPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mithra Pharmaceuticals SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 66.563 | ||
| EPS (TTM) ($) | -1.514 | ||
| Beta | 0.56 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 6.75 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 6.75 - 6.75 | ||
| Shares Outstanding (Mil) | 66.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mithra Pharmaceuticals SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mithra Pharmaceuticals SA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mithra Pharmaceuticals SA Frequently Asked Questions
What is Mithra Pharmaceuticals SA(MITPF)'s stock price today?
The current price of MITPF is $6.75. The 52 week high of MITPF is $6.75 and 52 week low is $6.75.
When is next earnings date of Mithra Pharmaceuticals SA(MITPF)?
The next earnings date of Mithra Pharmaceuticals SA(MITPF) is 2025-03-07 Est..
Does Mithra Pharmaceuticals SA(MITPF) pay dividends? If so, how much?
Mithra Pharmaceuticals SA(MITPF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers